Keywords: ivax, licenses, drug, multiple, sclerosis, corp, entered

IVAX licenses drug for multiple sclerosis

Article | 07 December 2000

Print This

IVAX Corp has entered into an exclusive worldwide agreement with TheScripps Research Institute in the USA to develop and market ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in